Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
British Journal of Clinical Pharmacology|May 21, 1999
Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1-receptor antagonistS Chaufour, H Caplain, N Lilienthal, et al.
British Journal of Clinical Pharmacology|November 1, 1995
Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteersP Rosenzweig, H Caplain, S Chaufour, et al.
Arzneimittel-Forschung|October 29, 2000
Plasma levels of glyceryl trinitrate and dinitrates during application of three strengths of a new glyceryl trinitrate transdermal patchA Santoro, L C Rovati, M Follet, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Comparative bioequivalence study of a new levothyroxine solution versus a reference L-thyroxine solution in normal healthy volunteersD Chassard, J C Kerihuel, H Caplain, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolitesJ M Kovarik, E A Mueller, H Zehender, et al.
Journal of Clinical Pharmacology|January 1, 1996
Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastineJ L Pinquier, H Caplain, M J Cabanis, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Development and pharmacokinetics of a new sustained-release formulation of diltiazemJ F Thiercelin, J Necciari, H Caplain, et al.
Annals of Allergy|August 1, 1992
Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamineP Rosenzweig, J J Thebault, H Caplain, et al.
Thrombosis and Haemostasis|November 1, 1994
The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteersA V Bendetowicz, H Kai, R Knebel, et al.
Thrombosis and Haemostasis|April 1, 1995
Comparison of the pharmacokinetic profiles of three low molecular mass heparins--dalteparin, enoxaparin and nadroparin--administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism)F Collignon, A Frydman, H Caplain, et al.
Pageof 3